Medicine in use for diagnosing gastric cancer, and preparation method
A drug and a technology for gastric cancer, applied in the field of drugs for gastric cancer diagnosis and their preparation, can solve problems such as the influence of antibody activity, and achieve the effects of improving uptake, reducing influence and enhancing stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] A drug for the diagnosis of gastric cancer, comprising an antibody and a radionuclide, the antibody is a monoclonal antibody 3H11, the radionuclide is labeled with a bifunctional linker to the monoclonal antibody 3H11, and the radionuclide is labeled The monoclonal antibody 3H11 is a colorless transparent liquid injection.
[0046] In the present invention, the monoclonal antibody 3H11 includes murine antibodies and fragments, single-chain antibodies (ScFv), double-chain antibodies (Diabody), miniaturized antibodies (Minibody) and chimeric antibodies (Chimeric) prepared by genetic engineering. .
[0047] In the present invention, the radionuclide is 99m Tc (technetium-99m), the bifunctional linker is S-HYNIC (succinimidyl-hydrazinonicotinamide, abbreviated as S-HYNIC), the radionuclide-labeled monoclonal antibody formed radiopharmaceuticals are 99m Tc-HYNIC-3H11.
[0048] The monoclonal antibody 3H11 is coupled and purified using the following methods:
[0049] Mix...
Embodiment 2
[0072] In this embodiment, the monoclonal antibody 3H11 is labeled with another radionuclide, which is 111 In (indium-111), the bifunctional linker is DOTA (1,4,7,10-tetraazacyclododecane-N′, N″, N, N″″-tetraacetic acid, 1, 4,7,10-tetraazacyclododecanetetraacetic acid), the radiopharmaceutical formed by the radionuclide-labeled monoclonal antibody is 111 In-DOTA-3H11.
[0073] In the present invention, the bifunctional linker includes a derivative of DOTA.
[0074] In the present invention, the bifunctional linker includes DTPA (diethylenetriaminepenta-acetic acid, diethylenetriaminepenta-acetic acid).
[0075] In the present invention, the bifunctional linker includes derivatives of DTPA
[0076] 111 In is another radionuclide with excellent physical properties, suitable for nuclear medicine imaging. 111 In-labeled antibodies still require indirect labeling, that is, introducing a bifunctional linker between the antibody and the radionuclide, generally DOTA and its deri...
Embodiment 3
[0094] A preparation method of a medicine for gastric cancer diagnosis, the steps are as follows:
[0095] 1. Mix 0.9mL concentration of 5.0mg / mL monoclonal antibody 3H11 solution with 5μL concentration of 1.55×10 -2 The mg / mL S-HYNIC solution was added to the reaction tube, and the reaction was carried out at 4°C in the dark for 5 hours; the molar ratio of S-HYNIC and monoclonal antibody 3H11 in this reaction was 8:1; the reaction solution was obtained after the reaction was completed ;
[0096] II. The reaction solution was dialyzed twice with a citric acid buffer solution with a pH value of 7.4 and a concentration of 20 mM, each dialysis time was 8 hours, and the citric acid buffer solution used contained 100 mM NaCl; The final reaction solution was dialyzed 2 times with a citric acid buffer solution with a pH value of 5.2 and a concentration of 20 mM. The dialysis time was 8 hours each time. The citric acid buffer solution used contained 100 mMNaCl. After the dialysis tre...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com